TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells.
Jiacheng BiChen HuangXiaomeng JinChaoyue ZhengYingying HuangXiaohu ZhengZhigang TianHaoyu SunPublished in: Journal for immunotherapy of cancer (2023)
This study highlighted TIPE2 targeting as a promising approach for enhancing adoptive NK cell therapy against solid tumors.